Thanks for joining me on episode 24 of the podcast, where I speak with Dr Ben Sessa. Ben is a consultant psychiatrist, psychedelic therapist and chief medical officer at Awakn Life Sciences, the UK’s first on-the-high-street provider of psychedelic-assisted psychotherapy. Awakn is researching, developing and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions.

In today’s episode, Ben talks to me about Ketamine-Assisted Psychotherapy, otherwise known as KAP. We talk about the emergence of KAP and how it differs from ketamine infusion therapy, how someone trains to be a psychedelic therapist, ketamine and psychological flexibility, how safe ketamine is, how patients describe their experience of taking ketamine and what the future holds for KAP.